	Development of a Prognostic Survival Risk Score for Lung Cancer Patients With Type 2 Diabetes Mellitus: A Territory-Wide Retrospective Cohort Study. Cancer Med Zhong CC, Huang J, Li Z, Jiang Y, Yang Z, Yuan J, Huang X, Liu X, Wang H, Poon J, Dou Q, Sung A, Wong MCS. PMID: 42655935 [PubMed - in process]
	Prognostic Value of the Lung Immune Prognostic Index in Metastatic Renal Cell Carcinoma Treated With Second-Line Immunotherapy. Int J Urol Özberk U, Perkin P, Ye, Alg, Karaka, Ak, Uçar G. PMID: 42655932 [PubMed - indexed for MEDLINE]
	Erythrocyte Transfusion as an Independent Predictor of Survival but Not Immune-Related Toxicity in Nivolumab-Treated Metastatic NSCLC: A Multicenter Cohort. Medicina (Kaunas) Fidan MC, Çiçek E, Abbasov H, Guliyev M, Çerme E, Akkaya K, Do, Majidova N, Paçac, Türko, Ekinci Fidan M, Çelik E, Y, Bayo, Alan Ö, Demirci NS. PMID: 42654498 [PubMed - indexed for MEDLINE]
	Impact of COVID-19 Vaccination on Patients with Non-Small Cell Lung Cancer Receiving First-Line Immune Checkpoint Inhibitor Therapy: Real-World Evidence from Romania. Medicina (Kaunas) Gheorghi, Cotan HT, Pistol A, Orlov-Slavu CM, Tianu E, Lazar AT, Stanciu M, Radoi I, Mitroi L, Ni. PMID: 42654486 [PubMed - indexed for MEDLINE]
	Dosimetric Evaluation of MR-Guided IMRT and VMAT Techniques for Early-Stage Glottic Cancer: A Pilot Comparative Planning Study. Medicina (Kaunas) Rud, Jaselsk, Laurikaitien, , Adlien. PMID: 42654404 [PubMed - indexed for MEDLINE]
	Magnetic Hyperthermia via Zn(0.2)Mn(0.8)Fe(2)O(4) Oleic Acid Nanoparticles Enhances Chemotherapy Efficacy in a Lewis Lung Carcinoma Model. Pharmaceutics Yakobson DE, Zharkov MN, Kulikov OA, Kulikova VI, Bobrov VS, Makarov AO, Brodovskaya EP, Balykova LA, Yan R, Pyataev NA. PMID: 42654138 [PubMed]
	Anti-TROP2 Antibody Drug Conjugates in EGFR-Mutant Non-Small Cell Lung Cancer: Biological Rationale and Clinical Challenges. Pharmaceutics Bonanno L, Ronchi A, Bao LC, Pante F, Sangiorgi S, Pasello G, Indraccolo S, Guarneri V. PMID: 42654023 [PubMed]
	Emerging Therapeutic Strategies in Small-Cell Lung Cancer: From Adaptive Resistance to Precision Therapy. Pharmaceuticals (Basel) Kim J, Kang S. PMID: 42653714 [PubMed]
	Smoking-Stratified Signal Decomposition and Feature Selection for Never-Smoker Cancer Classification in a Combined Lung-Breast Metabolomics Cohort. Int J Mol Sci Popuri B, Haince JF, Bux RA, Huang G, Tappia PS, Ramjiawan B, Vaida M. PMID: 42653353 [PubMed - indexed for MEDLINE]
	The Role of Alternative Splicing in Lung Cancer: Mechanisms, Regulators, and Therapeutic Implications. Int J Mol Sci Shang L, Wang N, Liu Q, Chen L, Liu H. PMID: 42653273 [PubMed - indexed for MEDLINE]
	Rewiring the Molecular Interplay of CDK4/6 Inhibitors in Lung Cancer: From Cell Cycle Control to Immune Microenvironment Remodeling. Int J Mol Sci Ku Y, Zheng Y, Ding Y, Zhang P, Wu X, Chen Y. PMID: 42653126 [PubMed - indexed for MEDLINE]
	Characterization of Patients with Non-Small Cell Lung Cancer Using Machine Learning Tools: Relationship with Prognostic Biomarkers and Overall Survival-A Pilot Study. J Clin Med Lojo-Rodríguez I, Casal-Guisande M, Botana-Rial M, Ramos-Hernández C, Leiro-Fernández V, González-Montaos A, Pou-Álvarez C, Fernández-Villar A. PMID: 42652844 [PubMed]
	Quantitative Immunohistochemical Landscapes and Chemoimmunotherapy Outcomes of ASCL1, NEUROD1, POU2F3, and YAP1 in Pure Small-Cell Lung Cancer: A Pilot Study. J Clin Med Aydinalp Camadan Y, Demir Ispir A, Kilic Bagir E, Mete B, Asoglu H, Turker M, Yaslikaya S, Kidi MM, Biter S, Asarkaya E, Atas Ipek S, Koseci T, Bayram E, Sahin B, Gumurdulu D, Kara IO. PMID: 42652818 [PubMed]
	Clinicopathological Characteristics, Molecular Findings, and Survival of Lung Cancer in Adults Aged <30 Years in China: A Retrospective Cohort Study. J Clin Med Zhang J, Zhou J. PMID: 42652764 [PubMed]
	Efficacy and Safety of Moderate-Dose Stereotactic Body Radiation Therapy (SBRT) for Patients with Oligometastatic Lung Cancer Unfit for Standard SBRT: A Preliminary Single-Center Study. J Clin Med Park J, Bae BK, Kang MK, Park J. PMID: 42652741 [PubMed]
	Baseline Neutrophil-to-Lymphocyte Ratio and Two-Year Incident Distant Metastasis in Stage I-III Lung Cancer: A Single-Center Retrospective Cohort Study. J Clin Med Wang Y, Zhang J, Liu X, Zhuang X, Zhang Q. PMID: 42652611 [PubMed]
	Preoperative CT Radiomics for Assessing Pathological Response to Neoadjuvant Chemoimmunotherapy in Locally Advanced Non-Small-Cell Lung Cancer. J Clin Med Trabalza Marinucci B, Palmeri F, Caruso D, Mancini M, Piccioni G, Messa F, Ciccone AM, Maurizi G, Rendina EA, Ibrahim M. PMID: 42652554 [PubMed]
	Examining Community Engagement Strategies Used in the Climate Impact on Lung Cancer via Exposure to Radon (CLOVER) Study. Int J Environ Res Public Health Srivastava M, Thoumi A, Raveendran Y, Gibson P, Iradukunda J, Joshi A, Ayangeakaa SD, Clarke JM, Koch A, Zhang JJ, Akinyemiju T. PMID: 42652387 [PubMed - indexed for MEDLINE]
	SEFA: Semantic Embedding-Based Feature Augmentation of Biomedical Language-Model Embeddings Improves Interpretable Metabolomic Prediction of Lung Cancer. Biomedicines Wu J, Haince JF, Bux RA, Huang G, Tappia PS, Ramjiawan B, Vaida M. PMID: 42652237 [PubMed]
	Immune Checkpoint Inhibitor-Related Pneumonitis in Renal Cell Carcinoma: Clinical Features, Mechanisms, and Lessons from Lung Cancer. Biomolecules Shtembari K, Catalano M, Vascotto IA, Calandrelli C, Mancini S, Pratesi L, Izzi M, Mela MM, Rossi V, Pillozzi S, Rodriguez-Vida A, Aseafan M, Nieto-Coronel MT, Santoni M, Antonuzzo L, Roviello G. PMID: 42650785 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 161583

Page 1 of 8080



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy